{"title":"Association of LILRB3 variants with kidney transplant failure in African Americans","authors":"Susan J. Allison","doi":"10.1038/s41581-025-00959-w","DOIUrl":null,"url":null,"abstract":"<p>African American kidney transplant recipients exhibit a higher risk of graft failure than other racial and ethnic groups even after accounting for HLA mismatches and socioeconomic status, which suggests a role for other risk factors. Now, researchers have identified a cluster of four consecutive missense single-nucleotide polymorphisms (SNPs) within leukocyte immunoglobulin-like receptor B3 (<i>LILRB3</i>) that is enriched among African American individuals and represents a risk factor for death-censored graft loss and immune-related diseases.</p><p>Using this approach, the researchers uncovered a cluster of four linked missense SNPs in <i>LILRB3</i> (termed <i>LILRB3-</i>4SNPs) that was predominantly detected in African American individuals and associated with poor graft outcomes. Further evaluation in other transplantation cohorts and biobank data revealed that <i>LILRB3-</i>4SNPs correlates with a heightened risk of graft loss and progression to kidney failure. These analyses also identified an association between <i>LILRB3-</i>4SNPs and immune-related pathologies, in line with the known role of <i>LILRB3</i> as a negative regulator of immune responses. Multiomics analyses also demonstrated that transplant recipients with <i>LILRB3-</i>4SNPs demonstrate increased inflammation characterized by persistent activation of T cell and B cell signalling pathways, and monocyte ferroptosis, whereas functional studies in a macrophage cell line demonstrated that the pathogenic effects of <i>LILRB3-</i>4SNPs expression could be reversed by a ferroptosis inhibitor. “This work bridges genetic discovery with translational medicine, offering a pathway to address disparities in transplantation outcomes through precision therapies,” says Zhang. The researchers are now planning further studies to establish the <i>LILRB3-</i>4SNPs cluster as a genetic biomarker for the stratification of graft failure risk in African American transplant recipients and evaluate the efficacy of ferroptosis inhibitors in preclinical models.</p>","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":"33 1","pages":""},"PeriodicalIF":28.6000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Reviews Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41581-025-00959-w","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
African American kidney transplant recipients exhibit a higher risk of graft failure than other racial and ethnic groups even after accounting for HLA mismatches and socioeconomic status, which suggests a role for other risk factors. Now, researchers have identified a cluster of four consecutive missense single-nucleotide polymorphisms (SNPs) within leukocyte immunoglobulin-like receptor B3 (LILRB3) that is enriched among African American individuals and represents a risk factor for death-censored graft loss and immune-related diseases.
Using this approach, the researchers uncovered a cluster of four linked missense SNPs in LILRB3 (termed LILRB3-4SNPs) that was predominantly detected in African American individuals and associated with poor graft outcomes. Further evaluation in other transplantation cohorts and biobank data revealed that LILRB3-4SNPs correlates with a heightened risk of graft loss and progression to kidney failure. These analyses also identified an association between LILRB3-4SNPs and immune-related pathologies, in line with the known role of LILRB3 as a negative regulator of immune responses. Multiomics analyses also demonstrated that transplant recipients with LILRB3-4SNPs demonstrate increased inflammation characterized by persistent activation of T cell and B cell signalling pathways, and monocyte ferroptosis, whereas functional studies in a macrophage cell line demonstrated that the pathogenic effects of LILRB3-4SNPs expression could be reversed by a ferroptosis inhibitor. “This work bridges genetic discovery with translational medicine, offering a pathway to address disparities in transplantation outcomes through precision therapies,” says Zhang. The researchers are now planning further studies to establish the LILRB3-4SNPs cluster as a genetic biomarker for the stratification of graft failure risk in African American transplant recipients and evaluate the efficacy of ferroptosis inhibitors in preclinical models.
期刊介绍:
Nature Reviews Nephrology aims to be the premier source of reviews and commentaries for the scientific communities it serves.
It strives to publish authoritative, accessible articles.
Articles are enhanced with clearly understandable figures, tables, and other display items.
Nature Reviews Nephrology publishes Research Highlights, News & Views, Comments, Reviews, Perspectives, and Consensus Statements.
The content is relevant to nephrologists and basic science researchers.
The broad scope of the journal ensures that the work reaches the widest possible audience.